Zacks Investment Research downgraded shares of MESA LABS INC (MLAB) from OUTPERFORM to NEUTRAL on December 26, 2012, with a target price of $52.20.
MESA LABORATORIES, INC. designs, develops, acquires, manufactures and markets instruments and systems utilized in connection with industrial applications and hemodialysis therapy.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on MESA LABS INC (MLAB),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment